Varicella Vaccine: a Molecular Variant That May Contribute to Attenuation

por Gershon, Anne A., Gershon, Michael D.
Publicado 2022

Clinical Features of Varicella-Zoster Virus Infection

por Kennedy, Peter G. E., Gershon, Anne A.
Publicado 2018

Safety and Varicella Outcomes in In Utero–Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Pr...

por Duchon, Jennifer M, Levin, Myron J, Gershon, Anne A
Publicado 2019

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster

por Gershon, Anne A, Gershon, Michael D, Shapiro, Eugene D
Publicado 2021

Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms

por Depledge, Daniel P., Yamanishi, Koichi, Gomi, Yasuyuki, Gershon, Anne A., Breuer, Judith
Publicado 2016

Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes...

por Levin, Myron J., Duchon, Jennifer M., Swamy, Geeta K., Gershon, Anne A.
Publicado 2019

Communicability of varicella before rash onset: a literature review

por Marin, Mona, Leung, Jessica, Lopez, Adriana S., Shepersky, Leah, Schmid, D. Scott, Gershon, Anne A.
Publicado 2021

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus i...

por Sauboin, Christophe, Holl, Katsiaryna, Bonanni, Paolo, Gershon, Anne A., Benninghoff, Bernd, Carryn, Stephane, Burgess, Margaret A., Wutzler, Peter
Publicado 2019

Rates of Vaccine Evolution Show Strong Effects of Latency: Implications for Varicella Zoster Virus Epidemiology

por Weinert, Lucy A., Depledge, Daniel P., Kundu, Samit, Gershon, Anne A., Nichols, Richard A., Balloux, Francois, Welch, John J., Breuer, Judith
Publicado 2015

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine

por Casper, Corey, Corey, Lawrence, Cohen, Jeffrey I., Damania, Blossom, Gershon, Anne A., Kaslow, David C., Krug, Laurie T., Martin, Jeffrey, Mbulaiteye, Sam M., Mocarski, Edward S., Moore, Patrick S., Ogembo, Javier Gordon, Phipps, Warren, Whitby, Denise, Wood, Charles
Publicado 2022

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

por Hoft, Daniel F., Blazevic, Azra, Selimovic, Asmir, Turan, Aldin, Tennant, Jan, Abate, Getahun, Fulkerson, John, Zak, Daniel E., Walker, Robert, McClain, Bruce, Sadoff, Jerry, Scott, Judy, Shepherd, Barbara, Ishmukhamedov, Jasur, Hokey, David A., Dheenadhayalan, Veerabadran, Shankar, Smitha, Amon, Lynn, Navarro, Garnet, Podyminogin, Rebecca, Aderem, Alan, Barker, Lew, Brennan, Michael, Wallis, Robert S., Gershon, Anne A., Gershon, Michael D., Steinberg, Sharon
Publicado 2016